Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor

New England Journal of Medicine

Volumn 339, Issue 17, 1998, Pages 1177-1185

  Sasazuki, Takehiko ^a   Juji, Takeo ^c   Morishima, Yasuo ^d   Kinukawa, Naoko ^b   Kashiwabara, Hidehiko ^e   Inoko, Hidetoshi ^f   Yoshida, Takato ^g   Kimura, Akinori ^h   Akaza, Tatsuya ^c   Kamikawaji, Nobuhiro ^a   Kodera, Yoshihisa ⁱ   Takaku, Fumimaro ^j   Nose, Yoshiaki ^b   Ono, Takashi ^a   Sakamaki, Takeo ^e   Kato, Shunichi ^f   Akiyama, Yuichi ^k   Okamoto, Shinichiro ^l   Dohy, Hiroo ^m   Harada, Mine ⁿ   Asano, Shigetaka ^o   more..

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

^e SAKURA NATIONAL HOSPITAL   (Japan)

^f TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h Japan Red Cross Nagoya First Hosp ^*  (Japan)

ⁱ JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^j JICHI MEDICAL UNIVERSITY   (Japan)

^k KYOTO UNIVERSITY   (Japan)

^l KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^m ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

ⁿ OKAYAMA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^o THE UNIVERSITY OF TOKYO   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW DEPRESSION; CHILD; CONTROLLED STUDY; DEATH; DNA DETERMINATION; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ALLELES; CHILD; CHILD, PRESCHOOL; FEMALE; GENES, MHC CLASS I; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY TESTING; HUMANS; INFANT; LEUKEMIA; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 0032558686     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199810223391701     Document Type: Article

References (44)

1. Thomas ED. Marrow transplantation for malignant diseases. J Clin Oncol 1983;1:517-31.
2. O'Reilly RJ. Allogenic bone marrow transplantation: current status and future directions. Blood 1983;62:941-64.
3. Champlin RE, Gale RP. Role of bone marrow transplantation in the treatment of hematologic malignancies and solid tumors: critical review of syngeneic, autologous, and allogeneic transplants. Cancer Treat Rep 1984; 68:145-61.
4. Bortin MM, Horowitz MM, Gale RP, et al. Changing trends in allogeneic bone marrow transplantation for leukemia in the 1980s. JAMA 1992; 268:607-12.
5. Hirabayashi N, Kodera Y, Matsuyama T, et al. Bone marrow transplantation in 614 patients: twenty year experience of the Nagoya Bone Marrow Transplantation Group (NBMTG). Transplant Proc 1995;27:1380-2.
6. Hansen JA, Petersdorf E, Martin PJ, Anasetti C. Hematopoietic stem cell transplants from unrelated donors. Immunol Rev 1997;157:141-51.
7. Dupont B. Immunology of hematopoietic stem cell transplantation: a brief review of its history. Immunol Rev 1997;157:5-12.
8. Beatty PG, Anasetti C, Hansen JA, et al. Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus. Blood 1993;81:249-53.
9. Davies SM, Shu XO, Blazar BR, et al. Unrelated donor bone marrow transplantation: influence of HLA A and B incompatibility on outcome. Blood 1995;86:1636-42.
10. Spencer AP, Brookes PA, Kaminski E, et al. Cytotoxic T lymphocyte precursor frequency analyses in bone marrow transplantation with volunteer unrelated donors: value in donor selection. Transplantation 1995;59: 1302-8.
11. Hows JM, Yin JL, Marsh J, et al. Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemia. Blood 1986;68:1322-8.
12. McCullough J, Rogers G, Dahl R, et al. Development and operation of a program to obtain volunteer bone marrow donors unrelated to the patient. Transfusion 1986;26:315-23.
13. McElligott MC, Menitove JE, Aster RH. Recruitment of unrelated persons as bone marrow donors: a preliminary experience. Transfusion 1986;26:309-14.
14. Bodmer JG, Marsh SG, Albert ED, et al. Nomenclature for factors of the HLA system, 1996. Tissue Antigens 1997;49:297-321.
15. Kimura A, Dong RP, Harada H, Sasazuki T. DNA typing of HLA class II genes in B-lymphoblastoid cell lines homozygous for HLA. Tissue Antigens 1992;40:5-12.
16. Kimura A, Sasazuki T. Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991: proceedings of the Eleventh International Histocompatibility Workshop and Conference. Vol. 1. Oxford, England: Oxford University Press, 1992:397-419.
17. Date Y, Kimura A, Kato H, Sasazuki T. DNA typing of HLA-A gene: population study and identification of four new alleles in Japanese. Tissue Antigens 1996;47:93-101.
18. Yasunaga S, Kimura A, Hamaguchi K, Rønningen KS, Sasazuki T. Different contribution of HLA-DR and DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM). Tissue Antigens 1996;47:37-48.
19. Tokunaga K, Ishikawa Y, Ogawa A, et al. Sequence-based association analysis of HLA class I and II alleles in Japanese supports conservation of common haplotypes. Immunogenetics 1997;46:199-205.
20. Matsubara K, Koide Y, Kobayashi A, et al. A rapid and sensitive method of HLA-DRB1 typing by acridinium-ester-labeled DNA probes. Hum Immunol 1992;35:132-9.
21. Inoko H, Ota M. PCR-RFLP. In: Hui KM, Bidwell JL, eds. Handbook of HLA typing techniques. Boca Raton, Fla.: CRC Press, 1993:9-70.
22. Naruse TK, Ando R, Nose Y, et al. HLA-DRB4 genotyping by PCR-RFLP: diversity in the associations between HLA-DRB4 and DRB1 alleles. Tissue Antigens 1997;49:152-9.
23. Kimura A, Hoshino S, Yoshida M, Harada H, Sasazuki T. Polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) analysis of HLA genes: a practical HLA-matching system. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991: proceedings of the Eleventh International Histocompatibility Workshop and Conference. Vol. 1. Oxford, England: Oxford University Press, 1992:511-4.
24. Ando H, Mizuki N, Ando R, et al. HLA-C genotyping in the Japanese population by the PCR-SSP method. Tissue Antigens 1996;48:55-8.
25. Speiser DE, Tiercy JM, Rufer N, et al. High resolution HLA matching associated with decreased mortality after unrelated bone marrow transplantation. Blood 1996;87:4455-62.
26. Santamaria P, Reinsmoen NL, Lindstrom AL, et al. Frequent HLA class I and DP sequence mismatches in serologically (HLA-A, HLA-B, HLA-DR) and molecularly (HLA-DRB1, HLA-DQA1, HLA-DQB1) HLA-identical unrelated bone marrow transplant pairs. Blood 1994;83: 280-7. [Erratum, Blood 1994;83:3834.]
27. Petersdorf EW, Longton GM, Anasetti C, et al. Definition of HLA-DQ as a transplantation antigen. Proc Natl Acad Sci U S A 1996;93:15358-63.
28. Petersdorf EW, Longton GM, Anasetti C, et al. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. Blood 1995;86:1606-13.
29. Petersdorf EW, Smith AG, Mickelson EM, et al. The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation. Blood 1993;81:1923-32.
30. Terasaki PI, McClelland JD. Microdroplet assay of human serum cytotoxins. Nature 1964;204:998-1000.
31. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974;18:295-304.
32. Kernan NA, Bartsch G, Ash RC, et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993;328:593-602.
33. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
34. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
35. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34: 187-220.
36. Dixon WJ, ed. BMDP statistical software manual. 3rd ed. Berkeley: University of California Press, 1992.
37. Morishima Y, Morishita Y, Tanimoto M, et al. Low incidence of acute graft-versus-host disease by the administration of methotrexate and cyclosporine in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings: possible role of genetic homogeneity. Blood 1989;74:2252-6.
38. Fleischhauer K, Zino E, Mazzi B, Severini GM, Benazzi E, Bordignon C. HLA-A02 subtype distribution in Caucasians from northern Italy: identification of A0220. Tissue Antigens 1996;48:673-9. [Erratum, Tissue Antigens 1997;50:208.]
39. Weiden PL, Flournoy N, Thomas ED, et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med 1979;300:1068-73.
40. Horowitz MM, Gale RP, Sondel PM, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990;75:555-62.
41. Hauch M, Gazzola MV, Small T, et al. Anti-leukemia potential of interleukin-2 activated natural killer cells after bone marrow transplantation for chronic myelogenous leukemia. Blood 1990;75:2250-62.
42. Moretta A, Biassoni R, Bottino C, et al. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev 1997;155:105-17.
43. Reyburn H, Mandelboim O, Vales-Gomez M, et al. Human NK cells: their ligands, receptors and functions. Immunol Rev 1997;155:119-25.
44. Moretta A, Moretta L. HLA class I specific inhibitory receptors. Curr Opin Immunol 1997;9:694-701.